Pharma & Bio
Technology
Kim Pil-han, CEO of iBeam Technology: "Successfully Supplied Products to Big Pharma Company Sanofi... Double Growth Expected This Year"
“We expect this year’s revenue to more than double compared to last year (approximately 4.2 billion won). Seasonally, the second half of the year always accounts for 60–70% of total revenue, but it ap…
Lifestyle
HLB Shares Surge on Hopes of FDA Review...Seers Predict a Rznomics Rally [K-Bio Pulse]
On June 16, South Korean pharmaceutical and biotechnology stocks were driven largely by company-specific catalysts, including regulatory expectations, business momentum, and shareholder-friendly initi…
Lifestyle
HLB Soars on Possibility of Written Review for New Liver Cancer Drug... Ciers and Algenomics Also Rise on Positive News [Bio Spotlight]
On the 16th, the pharmaceutical and biotech stock market saw a mixed performance among individual stocks as business momentum and shareholder returns intersected. Shares of HLB Group affiliates surged…
Lifestyle
Halozime Finally Abandons UK Patent… Good News for Alteogen? [Exclusive to Edaily]
#It has been confirmed that Altogen’s partner, Merck (MSD), has secured a complete victory in a lawsuit filed in the UK regarding Halozime’s European patent. With Halozime voluntarily revoking its UK …
Technology
SK Bioscience Forecasts Earnings Rebound, Led by Its Two Mainstays: CDMO and Next-Generation Pneumonia Vaccine
#SK Bioscience is aiming for a turnaround in its earnings by focusing on its contract development and manufacturing (CDMO) business and its 21-valent pneumococcal vaccine candidate, “GBP410.” As the c…
Technology
Genome & Company’s ‘Business Transformation’: ADC Trio as Future Growth Drivers
#Genome & Company is transforming from a microbiome company into a firm specializing in antibody-drug conjugates (ADCs). As recently as two years ago, the company was strongly associated with the deve…
Technology
G2G Bio Makes a Bold Move into the Next-Generation Obesity Treatment Market with Its Long-Acting Platform
#G2G Bio, a drug delivery system (DDS) platform company, is accelerating its push into the next-generation obesity treatment market by leveraging its long-acting drug delivery technology. G2G Bio is s…
Technology
Partnership with a Leading U.S. AI Healthcare Company Imminent... Signaling a Quantum Leap in Earnings [In-Depth Look at Medipixel ③]
For medical artificial intelligence (AI) companies, the domestic market is viewed as a valuable testing ground and home turf for validating their technological capabilities. However, to achieve sustai…
Technology
The “Lock-in Effect” Created by a “7-Second” Innovation… Non-Insured Services Take Flight [In-Depth Look at Medipixel ②]
The cardiovascular catheterization lab, where every second counts in emergency situations, is considered a veritable silent battlefield. In this high-pressure environment, where a patient’s life hinge…
Technology
CEO Song Gyo-seok: "We pivoted from lung cancer to cardiovascular AI diagnostics... and crossed the 'Valley of Death'" [In-Depth Look at Medipixel ①]
In the spring of 2016, the match between Lee Sedol, a 9-dan professional Go player, and the artificial intelligence (AI) program AlphaGo sent shockwaves around the world. While for some it was merely …